瑞芬太尼靶控输注在过度肥胖患者无痛胃镜检查中的应用
投稿时间:2016-08-22  修订日期:2016-09-05  点此下载全文
引用本文:张浩,刘存明.瑞芬太尼靶控输注在过度肥胖患者无痛胃镜检查中的应用[J].医学研究杂志,2017,46(4):154-156,153
DOI: 10.11969/j.issn.1673-548X.2017.04.039
摘要点击次数: 1130
全文下载次数: 874
作者单位E-mail
张浩 210011 南京医科大学第二附属医院麻醉科  
刘存明 210029 南京医科大学第一附属医院麻醉科 1335587409@qq.com 
中文摘要:目的 探讨瑞芬太尼靶控输注在过度肥胖患者无痛胃镜检查中的应用效果和安全性。方法 选取拟行无痛胃镜检查的过度肥胖患者100例,采用数字表法将其随机分为两组(n=50):瑞芬太尼靶控组(R组)和空白对照组(N组)。R组:采用靶控输注瑞芬太尼,血浆靶浓度为2ng/ml;N组:泵注同等容积的生理盐水。记录给药前(T0)、检查开始时(T1)、胃镜过声门时(T2)、检查结束时(T3)及术后5min(T4)的心率(HR)、血压(MAP)、呼吸频率(RR)。用Ramsay评分评价术中镇静作用;记录手术胃镜检查时间及术中低氧血症、体动反应、呼吸暂停、心动过缓和低血压等并发症的发生情况。记录两组患者、麻醉医生及内镜医生的满意度。结果 与N组相比,R组患者T1、T2、T3时HR、MAP,及术中体动反应发生率明显降低(P < 0.05),患者及内镜医生满意度明显增高(P < 0.05)。结论 瑞芬太尼靶控输注可在肥胖患者无痛胃镜检查中可产生良好的镇痛、镇静效果,是一种安全、有效的麻醉方法,值得临床推广。
中文关键词:瑞芬太尼  过度肥胖  无痛胃镜  靶控输注
 
Target-controlled Intravenous Analgesia with Remifentanil on Hyoxemia in Obese Patients with Painless Gastroscopy
Abstract:Objective To explor the safty and the effect of controlled intravenous analgesia with remifentanil on hyoxemia in obese patients with painless gastroscopy. Methods One hundred patients undergoing painless gastroscopy were randomly and equally allocated into 2 groups(50 each).In group R, anesthesia was induced with TCI(target-controlled infusion) of remifentanil,and the target plasma concentration (Cp)of propofol was set at 2ng/ml.In group N,the same volume of saline was continues infusion. MAP, RR and HR were monitored and recorded before the examination(T0),the time point of examination start(T1), gastroscopy go through glottis(T2), at the end of the operation (T3) and 5 min after examination (T4).The effect of sedation was evaluated by Ramsay.Except that, gastroscopy time, the satisfaction of patient,anesthetist and endoscopist were recored. In addition, apnea, bradycardia,hypoxemia, myoclonus, body movement,hypotension and postoperative complications were also recorded. Results Compared with group N, in group R,HR,MAP and rate of body movement were significantly decreased(P < 0.05). Except that,the satisfaction of patient and endoscopist were increased(P < 0.05). Conclusion TCI of remifentanil can provide satisfaction sedation for obese patients with painless gastroscopy with few adverse effects.
keywords:Remifentanil  Obese patients  Painless gastroscopy  Target-controlled intravenous
查看全文  查看/发表评论  下载PDF阅读器

京公网安备 11010502037822号